Assesment of scenarios based and intrafractional robustness of dynamic proton arc plans

被引:0
|
作者
Perez Moreno, J. M. [1 ]
Engwall, E. [2 ]
Wase, V. [2 ]
Castro Novais, J. [1 ]
Vera Sanchez, J. A. [1 ]
Cerron Campoo, F. [1 ]
Lorenzo Villanueva, I. [1 ]
Canals de las Casas, E. [1 ]
Martin, O. [2 ]
Sundstrom, J. [2 ]
Montero Feijoo, M. [1 ]
Sallabanda Hajro, M. [1 ]
de Pablo Gonzalez, A. [1 ]
Matute Martin, R. [1 ]
Miralbell, R. [1 ]
Mazal, A. [1 ]
机构
[1] Quironsalud Protontherapy Ctr, Radiat Oncol, Pozuelo De Alarcon, Madrid, Spain
[2] RaySearch Labs, Res & Dev, Stockholm, Sweden
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PO-1986
引用
收藏
页码:S1756 / S1758
页数:4
相关论文
共 50 条
  • [21] Optimizing the traversal time for gantry trajectories for proton arc therapy treatment plans
    Wase, V
    Marthin, O.
    Fredriksson, A.
    Finnson, A.
    PHYSICS IN MEDICINE AND BIOLOGY, 2024, 69 (06):
  • [22] Robustness of Volumetric-Modulated Arc Therapy (VMAT) Plans to Systematic MLC Positional Errors
    Qi, P.
    Xia, P.
    MEDICAL PHYSICS, 2014, 41 (06) : 318 - 318
  • [23] Comparing the Robustness of Intensity-modulated Proton Therapy and Proton-arc Therapy Against Interplay Effects of 4D Robust-optimised Plans for Lung Stereotactic Body Radiotherapy
    Wei, W. G.
    Yu, H.
    Xiao, Q.
    Li, Z. B.
    Li, J.
    Zhang, X. Y.
    Wu, Y. C.
    Qin, T. L.
    Zeng, X. H.
    Song, Y.
    Li, G. J.
    Bai, S.
    CLINICAL ONCOLOGY, 2025, 39
  • [24] ROBUSTNESS OF PROTON TREATMENT PLANS FOR CRANIAL TARGETS: THE INFLUENCE OF SETUP ERRORS AS A FUNCTION OF BEAM ARRANGEMENT
    Hopfgartner, J.
    Stock, M.
    Georg, D.
    RADIOTHERAPY AND ONCOLOGY, 2012, 102 : S84 - S85
  • [25] Robustness evaluation of Intensity Modulated Proton Therapy plans using Dose Volume Population Histogram
    Nguyen, Thu T. C.
    Nguyen, Binh T.
    Mai, Nhon V.
    PHYSICA MEDICA-EUROPEAN JOURNAL OF MEDICAL PHYSICS, 2019, 65 : 219 - 226
  • [26] Effect of breathing motion on robustness of locoregional proton plans for left-sided breast cancer
    Petoukhova, A.
    Klaassen, L.
    Habraken, S.
    Jacobs, J.
    Sattler, M.
    Verhoeven, K.
    Klaver, Y.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S862 - S863
  • [27] Validation of Portal Dosimetry As a Patient Specific Quality Assurance (PSQA) Device for Arc-Based Plans in Terms of Robustness to Known Errors
    Badry, F.
    Grelewicz, Z. R.
    Liao, Y.
    Turian, J. V.
    MEDICAL PHYSICS, 2024, 51 (10) : 7748 - 7749
  • [28] Secondary cancer risk estimates from proton arc plans in pediatric craniopharyngioma.
    Toussaint, L.
    Indelicato, D. J.
    Petersen, J. B.
    Stokkevag, C. H.
    Lassen-Ramshad, Y.
    Vestergaard, A.
    Muren, L. P.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1592 - S1593
  • [29] Evaluating Delivery-Time Reduction Strategies for Collimated Proton Arc Therapy Plans
    Wake, K. K.
    Bennett, L.
    Patwardhan, K. A.
    Smith, B. R.
    Culberson, W. S.
    Hyer, D. E.
    Flynn, R. T.
    Nelson, N. P.
    Hill, P. M.
    MEDICAL PHYSICS, 2024, 51 (09) : 6638 - 6638
  • [30] The impact of proton LET/RBE modeling and robustness analysis on base-of-skull and pediatric craniopharyngioma proton plans relative to VMAT
    Gutierrez, A.
    Rompokos, V.
    Li, K.
    Gillies, C.
    D'Souza, D.
    Solda, F.
    Fersht, N.
    Chang, Y. -C.
    Royle, G.
    Amos, R. A.
    Underwood, T.
    ACTA ONCOLOGICA, 2019, 58 (12) : 1765 - 1774